Myriad Genetics (MYGN) EPS (Basic) Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) EPS (Basic) Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -100.04% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 11.73% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 9.14% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 17.15% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -21.08% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 59.35% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -42.08% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 6.30% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 6.56% |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | -33,162.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33,162.97% |
| Dec 31, 2025 | 81.81% |
| Sep 30, 2025 | -21.05% |
| Jun 30, 2025 | -782.05% |
| Mar 31, 2025 | 99.62% |
| Dec 31, 2024 | -24.49% |
| Sep 30, 2024 | 67.52% |
| Jun 30, 2024 | 71.49% |
| Mar 31, 2024 | 57.02% |
| Dec 31, 2023 | 28.20% |
| Sep 30, 2023 | -72.08% |
| Jun 30, 2023 | -710.30% |
| Mar 31, 2023 | -162.89% |
| Dec 31, 2022 | -438.62% |
| Sep 30, 2022 | -239.32% |
| Jun 30, 2022 | -188.06% |
| Mar 31, 2022 | 50.76% |
| Dec 31, 2021 | 86.27% |
| Sep 30, 2021 | 253.42% |
| Jun 30, 2021 | 91.82% |